Etrasimod (APD334) is a potent and selective oral S1P1 receptor antagonist, with an IC50 of 1.88 nM in CHO cells. It is a valuable research tool for investigating S1P1 signaling in autoimmune and inflammatory disease models, both in vitro and in vivo.
Molekulargewicht:
457.48
Reinheit:
99.77% (May vary between batches)
CAS Nummer:
[1206123-37-6]
Formel:
C26H26F3NO3
Target-Kategorie:
S1P Receptor,LPL Receptor
Anwendungsbeschreibung:
Solubility: DMSO:25 mg/mL (54.65 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten